BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2883395)

  • 21. Expression of N-acetyl galactosaminylated and sialylated glycans by metastases arising from primary breast cancer.
    Brooks SA; Leathem AJ
    Invasion Metastasis; 1998-1999; 18(3):115-21. PubMed ID: 10474024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic contributions of Helix pomatia and carcinoembryonic antigen staining using histochemical techniques in breast carcinomas.
    Fukutomi T; Itabashi M; Tsugane S; Yamamoto H; Nanasawa T; Hirota T
    Jpn J Clin Oncol; 1989 Jun; 19(2):127-34. PubMed ID: 2733166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Helix pomatia lectin binding glycoproteins in women with breast cancer in relationship to their blood group phenotypes.
    Welinder C; Jansson B; Ferno M; Olson H; Baldetorp B
    J Proteome Res; 2009 Feb; 8(2):782-7. PubMed ID: 18998722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lectin Histochemistry for Metastasizing and Non-metastasizing Cancer Cells.
    Wolters-Eisfeld G; Schumacher U
    Methods Mol Biol; 2017; 1560():121-132. PubMed ID: 28155149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of the lectin Helix pomatia agglutinin (HPA) as a prognostic indicator and as a tool in cancer research.
    Mitchell BS; Schumacher U
    Histol Histopathol; 1999 Jan; 14(1):217-26. PubMed ID: 9987666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma.
    Liu D; Baltayan A; Naritoku WY; Barr NJ; Young LL; Chaiwun B; Tsao-Wei DD; Groshen SL; Taylor CR; Torloni H; Neville AM; Cote RJ; Imam SA
    Anticancer Res; 2000; 20(3A):1451-61. PubMed ID: 10928056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
    Luhtala S; Staff S; Tanner M; Isola J
    Tumour Biol; 2016 Jul; 37(7):9813-23. PubMed ID: 26810187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factor.
    Laack E; Nikbakht H; Peters A; Kugler C; Jasiewicz Y; Edler L; Hossfeld DK; Schumacher U
    Am J Pathol; 2002 Mar; 160(3):1001-8. PubMed ID: 11891197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do HPA and PHA-L have the same binding pattern in metastasizing human breast and colon cancers?
    Mitchell BS; Brooks SA; Leathem AJ; Schumacher U
    Cancer Lett; 1998 Jan; 123(1):113-9. PubMed ID: 9461027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis for recognition of breast and colon cancer epitopes Tn antigen and Forssman disaccharide by Helix pomatia lectin.
    Lescar J; Sanchez JF; Audfray A; Coll JL; Breton C; Mitchell EP; Imberty A
    Glycobiology; 2007 Oct; 17(10):1077-83. PubMed ID: 17652409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer.
    Rambaruth ND; Greenwell P; Dwek MV
    Glycobiology; 2012 Jun; 22(6):839-48. PubMed ID: 22322011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorship.
    Huseby RA; Ownby HE; Frederick J; Brooks S; Russo J; Brennan MJ
    J Clin Oncol; 1988 Jan; 6(1):83-8. PubMed ID: 3335894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lectin histochemistry of metastatic adenocarcinomas of the lung.
    Thöm I; Schult-Kronefeld O; Burkholder I; Goern M; Andritzky B; Blonski K; Kugler C; Edler L; Bokemeyer C; Schumacher U; Laack E
    Lung Cancer; 2007 Jun; 56(3):391-7. PubMed ID: 17306412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the binding of the lectin Helix pomatia agglutinin (HPA) of prognostic relevance in tumours of the upper aerodigestive tract?
    Schumacher DU; Randall CJ; Ramsay AD; Schumacher U
    Eur J Surg Oncol; 1996 Dec; 22(6):618-20. PubMed ID: 9005150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helix pomatia agglutinin binding activity is a predictor of survival time for patients with gastric carcinoma.
    Kakeji Y; Tsujitani S; Mori M; Maehara Y; Sugimachi K
    Cancer; 1991 Dec; 68(11):2438-42. PubMed ID: 1718583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous lectins with specificity to beta-galactosides and alpha- or beta-N-acetyl-galactosaminides in human breast cancer. Their glycohistochemical detection in tissue sections by synthetically different types of neoglycoproteins, their quantitation on cultured cells by neoglycoenzymes and their usefulness as targets in lectin-mediated phototherapy in vitro.
    Gabius HJ; Gabius S; Brinck U; Schauer A
    Pathol Res Pract; 1990 Oct; 186(5):597-607. PubMed ID: 2287587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
    Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
    Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.